Banque Cantonale Vaudoise Abbott Laboratories Transaction History

Banque Cantonale Vaudoise

$2.43 Billion
Q3 2024

A detailed history of Banque Cantonale Vaudoise transactions in Abbott Laboratories stock. As of the latest transaction made, Banque Cantonale Vaudoise holds 93,360 shares of ABT stock, worth $10.7 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

93,360

Previous 34,161 173.29%

Holding current value

$10.7 Million

Previous $3.55 Million 199.92%

% of portfolio

0.44%

Previous 0.14%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$100.07 - $118.13 $5.92 Million - $6.99 Million	59,199 Added 173.29%	93,360 $10.6 Million
Q2 2024 Jul 31, 2024	SELL	$100.73 - $112.44 $6.14 Million - $6.85 Million	-60,916 Reduced 64.07%	34,161 $3.55 Million
Q1 2024 Apr 10, 2024	BUY	$109.52 - $120.96 $411,795 - $454,809	3,760 Added 4.12%	95,077 $10.8 Million
Q4 2023 Feb 07, 2024	SELL	$90.19 - $110.4 $3.52 Million - $4.31 Million	-39,062 Reduced 29.96%	91,317 $10.1 Million
Q3 2023 Nov 08, 2023	SELL	$95.53 - $114.62 $171,476 - $205,742	-1,795 Reduced 1.36%	130,379 $12.6 Million
Q2 2023 Aug 09, 2023	BUY	$100.78 - $112.29 $424,888 - $473,414	4,216 Added 3.29%	132,174 $14.4 Million
Q1 2023 Apr 20, 2023	BUY	$96.86 - $114.01 $447,008 - $526,156	4,615 Added 3.74%	127,958 $13 Million
Q4 2022 Feb 10, 2023	BUY	$95.06 - $111.52 $82,797 - $97,133	871 Added 0.71%	123,343 $13.5 Million
Q3 2022 Oct 17, 2022	SELL	$96.76 - $112.03 $14,030 - $16,244	-145 Reduced 0.12%	122,472 $11.9 Million
Q2 2022 Aug 02, 2022	BUY	$102.07 - $123.37 $2.05 Million - $2.47 Million	20,054 Added 19.55%	122,617 $13.3 Million
Q1 2022 May 09, 2022	SELL	$114.02 - $139.04 $97,943 - $119,435	-859 Reduced 0.83%	102,563 $12.1 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $1 Million - $1.23 Million	-8,694 Reduced 7.75%	103,422 $14.6 Million
Q3 2021 Oct 29, 2021	BUY	$116.66 - $129.06 $6.85 Million - $7.58 Million	58,711 Added 109.94%	112,116 $13.2 Million
Q2 2021 Aug 11, 2021	SELL	$105.79 - $124.53 $1.81 Million - $2.13 Million	-17,074 Reduced 24.23%	53,405 $6.19 Million
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $248,046 - $292,236	-2,279 Reduced 3.13%	70,479 $8.45 Million
Q4 2020 Feb 05, 2021	BUY	$105.0 - $114.42 $50,925 - $55,493	485 Added 0.67%	72,758 $7.96 Million
Q3 2020 Oct 30, 2020	BUY	$91.64 - $111.29 $55,442 - $67,330	605 Added 0.84%	72,273 $7.87 Million
Q2 2020 Jul 22, 2020	BUY	$76.57 - $98.0 $191,578 - $245,196	2,502 Added 3.62%	71,668 $6.55 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $96,428 - $141,005	-1,535 Reduced 2.17%	69,166 $5.46 Million
Q4 2019 Feb 10, 2020	BUY	$78.51 - $87.4 $5.55 Million - $6.18 Million	70,701 New	70,701 $6.14 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.

Account

Banque Cantonale Vaudoise Abbott Laboratories Transaction History